Public References
Trust grows when complex biology becomes verifiable.
A curated selection of public sources covering science, BioVariance, media, talks, regional visibility, and current longevity work.
50+
scientific publications
2,000+
scientific citations
2013
BioVariance founded
TOP 100
innovation context
100+
public traces and references
Evidence map
Five Lines of Evidence
01
Scientific foundation
Bioinformatics, pharmaceutical data analysis, and complex biomedical systems form the foundation.
02
Entrepreneurial experience
BioVariance translated data-driven diagnostics, multi-omics, and personalized medicine into an operating company.
03
Media and interviews
Regional, specialist, and business media have covered the work from different angles over many years.
04
Networks and recognition
TOP 100, Medical Valley, BioPark, and regional ambassador roles show resonance beyond this website.
05
Longevity without hype
Current work turns biomarkers, aging biology, and prevention into realistic next decisions.
Trust in motion
One public trail. Many perspectives.
Not merely claimed, but traceable: science, entrepreneurship, media, networks, and the path toward a new longevity perspective.
Visible signal
50+ publications
Visualization: josef-scheiber.de
Science
ORCID
01 / 08
The scientific trail
Publications, research identity, and a professional path from bioinformatics to pharmaceutical data analysis.
Open original source ↗Selected sources
Curated Highlights
A deliberately small selection of the strongest sources before the full reference library.
Reference library
Reference Library
Grouped by trust logic rather than alphabetically: science, company history, media, region, stage, and current work.
01
Scientific Profiles & Talks
Profiles, publication context, and earlier presentation material.
02
BioVariance, Precision Medicine & Networks
Company history, network profiles, projects, and innovation context.
03
Media, Interviews & Specialist Articles
External coverage from regional, specialist, and business media.
CIO Views
CIO Views: Josef Scheiber
Interview / Feature
Basic Thinking
LET'S TALK BIZ: Dr. Josef Scheiber von BioVariance
Interview
StartupValley
Der Longevity Loop für Start-ups
Specialist article
AP Verlag
Der Longevity Loop
Specialist article
Werte & Wandel
Gesundheit designen
Interview
Die ZukunftsMacher
Vom Obstkorb zum Human Capital 3.0
Specialist article
Onpulson
Health KPIs für Führungskräfte
Specialist article
Onpulson
Ein Mitarbeitender mit 60-70 % Leistungskapazität
Interview
bindereport
Führung ist Biologie
Interview
04
Regional Public Life & Ecosystem
Upper Palatinate, Tirschenreuth, the returnee perspective, and regional media.
Oberpfalz.de
Josef Scheiber - Oberpfalz.de
Ambassador profile
Oberpfalz.de
Silicon Valley der Oberpfalz?
Regional article
Oberpfalz.de
Oberpfalz präsentiert neue Botschafter:innen
Regional article
OberpfalzECHO
Dr. Josef Scheiber ist jetzt Oberpfalz-Botschafter
Press article
OberpfalzECHO
Vier Erfolgsgeschichten: Die Macher der Nordoberpfalz
Press article
Wirtschaftsförderung Nordoberpfalz
Mit Gesundheit rechnen
Regional profile
Oberpfalz TV
OTV: BioVariance - Erfolgreiches Start-Up
TV / press
Oberpfalz TV
OTV: 913.000 Euro für BioVariance
TV / press
05
Podcasts, Video & Stage
Conversations, videos, speaker profiles, and public appearances.
YouTube / Oberpfalz
Rückkehrer - Dr. Josef Scheiber
Video
YouTube / Oberpfalz
Rocket Science made in Tirschenreuth
Video
YouTube / Podcast
Dr. Josef Scheiber, Biotech-Gründer aus Waldsassen
Podcast
YouTube
Souveränitäts Talk #68
Podcast
Podigee
Folge #68: Limit und Langlebigkeit
Podcast
Forever Young Summit
Forever Young Summit Stuttgart
Speaker / program
ITU
WSIS Forum 2025 - Josef Scheiber / BioVariance
Speaker profile
HalloPodcaster
HalloPodcaster: Dr. Josef Scheiber
Guest profile
06
Longevity & Current Work
Recent public sources on longevity, biomarkers, and prevention.
Context
Transparency matters
BioVariance's history also includes a restructuring and insolvency phase. I do not frame this as a blemish, but as part of real innovation work: science, technology, and business model have to become structurally viable. That experience now informs the focus on clear decision logic, realistic implementation, and robust structures.
How can this experience become useful for your question?
If you want to explore how multiomics, biomarkers, prevention, health-tech, or workplace health can turn data into decisions, an orientation call is the smallest useful next step.
Request orientation callNo spam. Just a personal note when something new appears.